METSYSTEM

Targeting Metastasis, transforming treatment

Munich, Denmark · Founded 2023 · $529K raised

Headquarters
Munich
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$529K
Last Round
$529K GrantMar 2023
Rounds
1

About

Metsystem develops METscreen, an advanced drug screen platform using patient-derived organoids and metastasis-targeting technologies to predict if and where cancer will spread and identify the most effective treatment for each patient. By bridging cutting-edge science with clinical application, Metsystem empowers doctors to make precise, informed treatment decisions based on the cancer's actual response.

Summary

METSYSTEM is a Healthcare company based in Munich, Denmark, founded in 2023. It has raised $529K in total across 1 round, most recently a $529K Grant round in Mar 2023. Investors include BioInnovation Institute.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantMar 2023
$529K

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

METSYSTEM on Indexed.vc
<a href="https://indexed.vc/companies/metsystem"><img src="https://indexed.vc/api/badge/company/metsystem" alt="METSYSTEM on Indexed.vc" width="260" height="76" /></a>